Cannassure Therapeutics (Israel) Market Value
| CSURE Stock | 717.00 62.80 8.05% |
| Symbol | Cannassure |
Cannassure Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cannassure Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cannassure Therapeutics.
| 12/14/2024 |
| 03/14/2025 |
If you would invest 0.00 in Cannassure Therapeutics on December 14, 2024 and sell it all today you would earn a total of 0.00 from holding Cannassure Therapeutics or generate 0.0% return on investment in Cannassure Therapeutics over 90 days. Cannassure Therapeutics is related to or competes with Intercure, Together Startup, and Amir Marketing. More
Cannassure Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cannassure Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cannassure Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0069 | |||
| Maximum Drawdown | 43.64 | |||
| Value At Risk | (11.77) | |||
| Potential Upside | 10.0 |
Cannassure Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cannassure Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cannassure Therapeutics' standard deviation. In reality, there are many statistical measures that can use Cannassure Therapeutics historical prices to predict the future Cannassure Therapeutics' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | 1.06 | |||
| Treynor Ratio | (0.95) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cannassure Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cannassure Therapeutics Backtested Returns
Cannassure Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0604, which signifies that the company had a -0.0604 % return per unit of risk over the last 3 months. Cannassure Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cannassure Therapeutics' Standard Deviation of 6.85, mean deviation of 4.79, and insignificant Risk Adjusted Performance to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.1, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cannassure Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cannassure Therapeutics is expected to be smaller as well. At this point, Cannassure Therapeutics has a negative expected return of -0.37%. Please make sure to confirm Cannassure Therapeutics' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Cannassure Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.18 |
Very weak predictability
Cannassure Therapeutics has very weak predictability. Overlapping area represents the amount of predictability between Cannassure Therapeutics time series from 14th of December 2024 to 28th of January 2025 and 28th of January 2025 to 14th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cannassure Therapeutics price movement. The serial correlation of 0.18 indicates that over 18.0% of current Cannassure Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 1129.41 |
Cannassure Therapeutics lagged returns against current returns
Autocorrelation, which is Cannassure Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cannassure Therapeutics' stock expected returns. We can calculate the autocorrelation of Cannassure Therapeutics returns to help us make a trade decision. For example, suppose you find that Cannassure Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cannassure Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cannassure Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cannassure Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cannassure Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Cannassure Therapeutics Lagged Returns
When evaluating Cannassure Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cannassure Therapeutics stock have on its future price. Cannassure Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cannassure Therapeutics autocorrelation shows the relationship between Cannassure Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Cannassure Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cannassure Stock Analysis
When running Cannassure Therapeutics' price analysis, check to measure Cannassure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannassure Therapeutics is operating at the current time. Most of Cannassure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cannassure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannassure Therapeutics' price. Additionally, you may evaluate how the addition of Cannassure Therapeutics to your portfolios can decrease your overall portfolio volatility.